Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.
about
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@en
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@nl
type
label
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@en
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@nl
prefLabel
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@en
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P50
P356
P1476
Mutant Kras- and p16-regulated ...... creatic ductal adenocarcinoma.
@en
P2093
Haoqiang Ying
Huamin Wang
Jianhua Ling
Lifeng Yang
Mien-Chie Hung
Paul J Chiao
P2860
P2888
P356
10.1038/NCOMMS14437
P407
P577
2017-02-24T00:00:00Z
P6179
1083862330